 |
 |
| Antinal ® |
| nifuroxazide |
|
| Broad spectrum intestinal antiseptic |
|
|
| Composition |
|
| Capsules: Each capsule contain: Nifuroxazide 200 mg. |
|
| Suspension: Each 5 mL suspension contains: Nifuroxazide 220 mg. |
|
|
| Properties |
|
|
|
|
| ANTiNAL® has a wide range of bactericidal activity against Gram positive and Gram negative enteropathogenic bacteria, e.g., Cambylobacter jejuni, Shigella, Salmonella, E. coli…etc. |
|
| ANTiNAL® is nonabsorbable and locally acting without systemic actions or side effects. |
| ANTiNAL® does not develop plasmid resistance and is effective against antibiotic resistant bacteria. |
|
| ANTiNAL®does not disturb the equilibrium of the intestinal flora. |
|
| ANTiNAL® activity is not affected by the pH of the stomach or food. |
|
| ANTiNAL® has an excellent tolerability and a wide safety margin, therefore it can be prescribed safely during pregnancy, lactation and infancy. |
|
| ANTiNAL® ensures rapid clinical response on the intestinal bacterial infections, thus helping prevent dehydration. |
|
| Indications |
|
 |
Acute and chronic bacterial diarrhea |
|
|
Gastroenteritis |
|
|
Acute and chronic colitis |
|
|
Intestinal antiseptic in all other types of diarrhea and intestinal infections to prevent superimposed bacterial infections. |
|
|
| Dosage |
|
| Unless otherwise prescribed by the physician, the usual dose is: |
|
| Adults: 1 capsule 4 times daily. |
|
| Children:Below 2 months: 1 teaspoonful (5 ml) twice daily. |
|
| 2 months - 1 year: 1 teaspoonful (5 ml) 3 times daily. |
| Over 1 year: 1 teaspoonful (5 ml) 4 times daily. |
|
|
| N.B.: | The dose can be increased according to the clinical response. |
|
|
| How Supplied |
|
| Capsules: Strips of 12 capsules in packs of 1 strip |
|
| Suspension: Bottles of 60 ml. |
|
|
| Product Ranking |
|
| Antinal is ranked #1 in the therapeutic group “Anti-Infective/Antidiarrhial” |
|
| Reference: Pharmaceutical Index, Egypt, IMS Health, Feb. 2003, www.imshealth.com. |
|
|
|
 |
|
| Product of: |
| Amoun Pharmaceutical Co.
S.A.E. |
| EI Salam City, Cairo, EGYPT. |
| Under Licence from: Lab.Roques, France. |
|
|
|